Haematological classification of the chronic myeloid leukaemias

Chronic myeloid leukaemia (CML) includes five subtypes, and the term should be used in the same way as the term chronic lymphoid leukaemia to refer to a group of related conditions. The subtypes of CML are: o 1. Chronic granulocytic leukaemia (CGL) (95% of all CML; 90% are Ph+, BCR+, 5% are Ph−, BCR...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Baillière's clinical haematology 1987-12, Vol.1 (4), p.887-906
Hauptverfasser: Shepherd, Patricia C.A., Ganesan, T.S., Galton, David A.G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 906
container_issue 4
container_start_page 887
container_title Baillière's clinical haematology
container_volume 1
creator Shepherd, Patricia C.A.
Ganesan, T.S.
Galton, David A.G.
description Chronic myeloid leukaemia (CML) includes five subtypes, and the term should be used in the same way as the term chronic lymphoid leukaemia to refer to a group of related conditions. The subtypes of CML are: o 1. Chronic granulocytic leukaemia (CGL) (95% of all CML; 90% are Ph+, BCR+, 5% are Ph−, BCR+) 2. Juvenile CML (extremely rare; Ph−, BCR− in the few so far examined) 3. Chronic neutrophilic leukaemia (CNL) (extremely rare; Ph−, BCR− in the few so far examined) 4. Chronic myelomonocytic leukaemia (CMML). CMML with low or normal leukocyte counts is classified as a myelodysplastic syndrome; CMML with high leukocyte count is both myelodysplastic and myeloproliferative. Ph−, BCR− 5. Atypical CML (aCML). Intermediate between CGL and CMML but has distinctive features. Ph−, mostly BCR−. Significance of few reported BCR+ uncertain. Markedly worse survival than CGL and probably worse than CMML. Definition needs refining. Types 2, 3, 4 and 5 account for 5% of all CML. CGL, CMML, aCML and CNL can be diagnosed in the great majority of cases from the morphological profile of presentation peripheral blood films, but high-quality Romanowsky staining is essential.
doi_str_mv 10.1016/S0950-3536(87)80031-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78050773</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0950353687800318</els_id><sourcerecordid>78050773</sourcerecordid><originalsourceid>FETCH-LOGICAL-c275t-651e498a7ff9b327559b5ffbba47dae325baac2a3356cf5b9f4f65368761a5253</originalsourceid><addsrcrecordid>eNqFkE1PwzAMhnMAjTH4CZN6QnAopE3TpKcJTYMhTeIAnKM0dVggbUbSIu3fk31oV062bL9-7QehaYbvM5yVD2-4ojgllJS3nN1xjEmW8jM0PpUv0GUIXxjnvCB8hEaEkJxTOkazpYRW9s66T6OkTZSVIRgd8964LnE66deQqLV3nVFJuwXrTJNYGL6jzshwhc61tAGuj3GCPp4W7_Nlunp9fpk_rlKVM9qnJc2gqLhkWlc1iSVa1VTrupYFaySQnNZSqlwSQkulaV3pQpfxbs7KTNKckgm6OezdePczQOhFa4ICa2UHbgiCcUwxYyQO0sOg8i4ED1psvGml34oMix0ssYcldlQEZ2IPS_Comx4NhrqF5qQ6kor92aEP8ctfA14EZaBT0BgPqheNM_84_AFq2nur</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78050773</pqid></control><display><type>article</type><title>Haematological classification of the chronic myeloid leukaemias</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Shepherd, Patricia C.A. ; Ganesan, T.S. ; Galton, David A.G.</creator><creatorcontrib>Shepherd, Patricia C.A. ; Ganesan, T.S. ; Galton, David A.G.</creatorcontrib><description>Chronic myeloid leukaemia (CML) includes five subtypes, and the term should be used in the same way as the term chronic lymphoid leukaemia to refer to a group of related conditions. The subtypes of CML are: o 1. Chronic granulocytic leukaemia (CGL) (95% of all CML; 90% are Ph+, BCR+, 5% are Ph−, BCR+) 2. Juvenile CML (extremely rare; Ph−, BCR− in the few so far examined) 3. Chronic neutrophilic leukaemia (CNL) (extremely rare; Ph−, BCR− in the few so far examined) 4. Chronic myelomonocytic leukaemia (CMML). CMML with low or normal leukocyte counts is classified as a myelodysplastic syndrome; CMML with high leukocyte count is both myelodysplastic and myeloproliferative. Ph−, BCR− 5. Atypical CML (aCML). Intermediate between CGL and CMML but has distinctive features. Ph−, mostly BCR−. Significance of few reported BCR+ uncertain. Markedly worse survival than CGL and probably worse than CMML. Definition needs refining. Types 2, 3, 4 and 5 account for 5% of all CML. CGL, CMML, aCML and CNL can be diagnosed in the great majority of cases from the morphological profile of presentation peripheral blood films, but high-quality Romanowsky staining is essential.</description><identifier>ISSN: 0950-3536</identifier><identifier>DOI: 10.1016/S0950-3536(87)80031-8</identifier><identifier>PMID: 3332855</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Blood Cell Count ; Bone Marrow - pathology ; Humans ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - blood ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - classification ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology ; Leukemia, Myelomonocytic, Chronic - physiopathology ; Leukocyte Count ; Philadelphia Chromosome ; Prognosis ; Translocation, Genetic</subject><ispartof>Baillière's clinical haematology, 1987-12, Vol.1 (4), p.887-906</ispartof><rights>1987 Baillière Tindall</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c275t-651e498a7ff9b327559b5ffbba47dae325baac2a3356cf5b9f4f65368761a5253</citedby><cites>FETCH-LOGICAL-c275t-651e498a7ff9b327559b5ffbba47dae325baac2a3356cf5b9f4f65368761a5253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3332855$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shepherd, Patricia C.A.</creatorcontrib><creatorcontrib>Ganesan, T.S.</creatorcontrib><creatorcontrib>Galton, David A.G.</creatorcontrib><title>Haematological classification of the chronic myeloid leukaemias</title><title>Baillière's clinical haematology</title><addtitle>Baillieres Clin Haematol</addtitle><description>Chronic myeloid leukaemia (CML) includes five subtypes, and the term should be used in the same way as the term chronic lymphoid leukaemia to refer to a group of related conditions. The subtypes of CML are: o 1. Chronic granulocytic leukaemia (CGL) (95% of all CML; 90% are Ph+, BCR+, 5% are Ph−, BCR+) 2. Juvenile CML (extremely rare; Ph−, BCR− in the few so far examined) 3. Chronic neutrophilic leukaemia (CNL) (extremely rare; Ph−, BCR− in the few so far examined) 4. Chronic myelomonocytic leukaemia (CMML). CMML with low or normal leukocyte counts is classified as a myelodysplastic syndrome; CMML with high leukocyte count is both myelodysplastic and myeloproliferative. Ph−, BCR− 5. Atypical CML (aCML). Intermediate between CGL and CMML but has distinctive features. Ph−, mostly BCR−. Significance of few reported BCR+ uncertain. Markedly worse survival than CGL and probably worse than CMML. Definition needs refining. Types 2, 3, 4 and 5 account for 5% of all CML. CGL, CMML, aCML and CNL can be diagnosed in the great majority of cases from the morphological profile of presentation peripheral blood films, but high-quality Romanowsky staining is essential.</description><subject>Blood Cell Count</subject><subject>Bone Marrow - pathology</subject><subject>Humans</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - blood</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - classification</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology</subject><subject>Leukemia, Myelomonocytic, Chronic - physiopathology</subject><subject>Leukocyte Count</subject><subject>Philadelphia Chromosome</subject><subject>Prognosis</subject><subject>Translocation, Genetic</subject><issn>0950-3536</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1PwzAMhnMAjTH4CZN6QnAopE3TpKcJTYMhTeIAnKM0dVggbUbSIu3fk31oV062bL9-7QehaYbvM5yVD2-4ojgllJS3nN1xjEmW8jM0PpUv0GUIXxjnvCB8hEaEkJxTOkazpYRW9s66T6OkTZSVIRgd8964LnE66deQqLV3nVFJuwXrTJNYGL6jzshwhc61tAGuj3GCPp4W7_Nlunp9fpk_rlKVM9qnJc2gqLhkWlc1iSVa1VTrupYFaySQnNZSqlwSQkulaV3pQpfxbs7KTNKckgm6OezdePczQOhFa4ICa2UHbgiCcUwxYyQO0sOg8i4ED1psvGml34oMix0ssYcldlQEZ2IPS_Comx4NhrqF5qQ6kor92aEP8ctfA14EZaBT0BgPqheNM_84_AFq2nur</recordid><startdate>198712</startdate><enddate>198712</enddate><creator>Shepherd, Patricia C.A.</creator><creator>Ganesan, T.S.</creator><creator>Galton, David A.G.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198712</creationdate><title>Haematological classification of the chronic myeloid leukaemias</title><author>Shepherd, Patricia C.A. ; Ganesan, T.S. ; Galton, David A.G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c275t-651e498a7ff9b327559b5ffbba47dae325baac2a3356cf5b9f4f65368761a5253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Blood Cell Count</topic><topic>Bone Marrow - pathology</topic><topic>Humans</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - blood</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - classification</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology</topic><topic>Leukemia, Myelomonocytic, Chronic - physiopathology</topic><topic>Leukocyte Count</topic><topic>Philadelphia Chromosome</topic><topic>Prognosis</topic><topic>Translocation, Genetic</topic><toplevel>online_resources</toplevel><creatorcontrib>Shepherd, Patricia C.A.</creatorcontrib><creatorcontrib>Ganesan, T.S.</creatorcontrib><creatorcontrib>Galton, David A.G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Baillière's clinical haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shepherd, Patricia C.A.</au><au>Ganesan, T.S.</au><au>Galton, David A.G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Haematological classification of the chronic myeloid leukaemias</atitle><jtitle>Baillière's clinical haematology</jtitle><addtitle>Baillieres Clin Haematol</addtitle><date>1987-12</date><risdate>1987</risdate><volume>1</volume><issue>4</issue><spage>887</spage><epage>906</epage><pages>887-906</pages><issn>0950-3536</issn><abstract>Chronic myeloid leukaemia (CML) includes five subtypes, and the term should be used in the same way as the term chronic lymphoid leukaemia to refer to a group of related conditions. The subtypes of CML are: o 1. Chronic granulocytic leukaemia (CGL) (95% of all CML; 90% are Ph+, BCR+, 5% are Ph−, BCR+) 2. Juvenile CML (extremely rare; Ph−, BCR− in the few so far examined) 3. Chronic neutrophilic leukaemia (CNL) (extremely rare; Ph−, BCR− in the few so far examined) 4. Chronic myelomonocytic leukaemia (CMML). CMML with low or normal leukocyte counts is classified as a myelodysplastic syndrome; CMML with high leukocyte count is both myelodysplastic and myeloproliferative. Ph−, BCR− 5. Atypical CML (aCML). Intermediate between CGL and CMML but has distinctive features. Ph−, mostly BCR−. Significance of few reported BCR+ uncertain. Markedly worse survival than CGL and probably worse than CMML. Definition needs refining. Types 2, 3, 4 and 5 account for 5% of all CML. CGL, CMML, aCML and CNL can be diagnosed in the great majority of cases from the morphological profile of presentation peripheral blood films, but high-quality Romanowsky staining is essential.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>3332855</pmid><doi>10.1016/S0950-3536(87)80031-8</doi><tpages>20</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0950-3536
ispartof Baillière's clinical haematology, 1987-12, Vol.1 (4), p.887-906
issn 0950-3536
language eng
recordid cdi_proquest_miscellaneous_78050773
source MEDLINE; Alma/SFX Local Collection
subjects Blood Cell Count
Bone Marrow - pathology
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - blood
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - classification
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology
Leukemia, Myelomonocytic, Chronic - physiopathology
Leukocyte Count
Philadelphia Chromosome
Prognosis
Translocation, Genetic
title Haematological classification of the chronic myeloid leukaemias
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T12%3A40%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Haematological%20classification%20of%20the%20chronic%20myeloid%20leukaemias&rft.jtitle=Bailli%C3%A8re's%20clinical%20haematology&rft.au=Shepherd,%20Patricia%20C.A.&rft.date=1987-12&rft.volume=1&rft.issue=4&rft.spage=887&rft.epage=906&rft.pages=887-906&rft.issn=0950-3536&rft_id=info:doi/10.1016/S0950-3536(87)80031-8&rft_dat=%3Cproquest_cross%3E78050773%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78050773&rft_id=info:pmid/3332855&rft_els_id=S0950353687800318&rfr_iscdi=true